XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Jan. 31, 2024   224,728      
Beginning balance at Jan. 31, 2024 $ 326,396 $ 2 $ 1,821,216 $ (236) $ (1,494,586)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares)   1,412      
Issuance of common stock upon the exercise of stock options 3,884   3,884    
Repurchases and retirement of common stock (in shares)   (5,940)      
Repurchases and retirement of common stock (74,690)       (74,690)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   7,252      
Issuance of common stock upon the vesting and settlement of restricted stock units (5)   (5)    
Issuance of common stock under employee share purchase plan (in shares)   1,119      
Issuance of common stock under employee share purchase plan 13,665   13,665    
Stock-based compensation expense 164,004   164,004    
Net unrealized gains on marketable securities 71     71  
Foreign currency translation adjustments (818)     (818)  
Net loss (193,237)       (193,237)
Ending balance (in shares) at Oct. 31, 2024   228,571      
Ending balance at Oct. 31, 2024 239,270 $ 2 2,002,764 (983) (1,762,513)
Beginning balance (in shares) at Jul. 31, 2024   229,489      
Beginning balance at Jul. 31, 2024 291,917 $ 2 1,942,911 (778) (1,650,218)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares)   739      
Issuance of common stock upon the exercise of stock options 1,755   1,755    
Repurchases and retirement of common stock (in shares)   (4,494)      
Repurchases and retirement of common stock (54,969)       (54,969)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   2,372      
Issuance of common stock upon the vesting and settlement of restricted stock units (1)   (1)    
Issuance of common stock under employee share purchase plan (in shares)   465      
Issuance of common stock under employee share purchase plan 4,799   4,799    
Stock-based compensation expense 53,300   53,300    
Net unrealized gains on marketable securities 33     33  
Foreign currency translation adjustments (238)     (238)  
Net loss (57,326)       (57,326)
Ending balance (in shares) at Oct. 31, 2024   228,571      
Ending balance at Oct. 31, 2024 239,270 $ 2 2,002,764 (983) (1,762,513)
Beginning balance (in shares) at Jan. 31, 2025   232,888      
Beginning balance at Jan. 31, 2025 $ 227,523 $ 2 2,059,848 (3,851) (1,828,476)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares) 857 857      
Issuance of common stock upon the exercise of stock options $ 2,835   2,835    
Repurchases and retirement of common stock (in shares)   (5,175)      
Repurchases and retirement of common stock (74,183)       (74,183)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   8,271      
Issuance of common stock upon the vesting and settlement of restricted stock units 0        
Issuance of common stock under employee share purchase plan (in shares)   1,252      
Issuance of common stock under employee share purchase plan 13,012   13,012    
Stock-based compensation expense 170,310   170,310    
Net unrealized gains on marketable securities 772     772  
Foreign currency translation adjustments 4,904     4,904  
Net loss (156,811)       (156,811)
Ending balance (in shares) at Oct. 31, 2025   238,093      
Ending balance at Oct. 31, 2025 188,362 $ 2 2,246,005 1,825 (2,059,470)
Beginning balance (in shares) at Jul. 31, 2025   236,345      
Beginning balance at Jul. 31, 2025 224,556 $ 2 2,183,543 1,263 (1,960,252)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon the exercise of stock options (in shares)   264      
Issuance of common stock upon the exercise of stock options 762   762    
Repurchases and retirement of common stock (in shares)   (2,183)      
Repurchases and retirement of common stock (30,785)       (30,785)
Issuance of common stock upon the vesting and settlement of restricted stock units (in shares)   3,166      
Issuance of common stock upon the vesting and settlement of restricted stock units 0        
Issuance of common stock under employee share purchase plan (in shares)   501      
Issuance of common stock under employee share purchase plan 5,266   5,266    
Stock-based compensation expense 56,434   56,434    
Net unrealized gains on marketable securities 652     652  
Foreign currency translation adjustments (90)     (90)  
Net loss (68,433)       (68,433)
Ending balance (in shares) at Oct. 31, 2025   238,093      
Ending balance at Oct. 31, 2025 $ 188,362 $ 2 $ 2,246,005 $ 1,825 $ (2,059,470)